AstraZeneca, Teva Reach Patent Deal Over Entocort
AstraZeneca LP has settled its infringement claims against Teva Pharmaceuticals USA Inc. over Entocort EC, striking a deal that will let the generic-drug maker start selling its own version of the...To view the full article, register now.
Already a subscriber? Click here to view full article